Cart (Loading....) | Create Account
Close category search window
 

Economic evaluation approaches for new technology

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)

The thrust of development supporting new medical devices and agents for the treatment of disease rightfully remains focused on the scientific and clinical underpinnings that justify the use of such new products and the replacement of others. Many devices and agents are introduced in the United States each year, and diagnostic and therapeutic regimens (standards of care) are often adapted to integrate new technology. When and how to use new devices and compounds can be problematic to clinicians, and it is difficult for payers (insurance companies and the federal government) to assess these new technologies for the purpose of coverage and reimbursement. For example, many chemotherapeutic compounds are effective as single agents but become even more effective when used in combination with other agents. In the most dramatic example, the development of new biologicals and immunotherapies continues at a brisk pace; these agents often display intricate chemical characteristics and represent the practical results of combinatorial and other advanced methodologies for synthesizing, and screening candidate molecules. Payers will have to make coverage decisions on these and other emerging technologies using methods involving health economics and health technology assessment. The economic valuation of new technology is an important tool for those making coverage and policy decisions. Here we explore some of the characteristics of economic valuations and their use.

Published in:

Engineering in Medicine and Biology Magazine, IEEE  (Volume:22 ,  Issue: 3 )

Date of Publication:

May-June 2003

Need Help?


IEEE Advancing Technology for Humanity About IEEE Xplore | Contact | Help | Terms of Use | Nondiscrimination Policy | Site Map | Privacy & Opting Out of Cookies

A not-for-profit organization, IEEE is the world's largest professional association for the advancement of technology.
© Copyright 2014 IEEE - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.